Physical Activity Monitoring Paediatric Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

August 1, 2018

Study Completion Date

August 1, 2018

Conditions
Diabetes Mellitus, Type 1
Interventions
BEHAVIORAL

physical activity monitor and feedback

Children will wear a Runscribe accelerometer for two weeks (children in Arm 2 will also wear a CGM). Runscribe will measure activity levels. Activity data will be downloaded by a researcher, analysed and graphs of daily activity levels prepared. At the child's next routine clinic appointment, child and parent will have 1:1 session with researcher acting as 'physical activity champion'. Session content will be informed by Phase 1, but will involve educational support around PA (including barriers and facilitators to participation) and individualised feedback on PA level). Individualised feedback will involve review of daily PA graphs - addressing times of high and low activity levels. For participants in Arm 2, there will also be review of daily line graphs showing BG trends. As part of standard clinical care, CGM data gets downloaded at routine clinic appointments and is visible on the patient's clinic notes in daily graph form.

Trial Locations (1)

Unknown

Sheffield Children's Hospital NHS Foundation Trust, Sheffield

All Listed Sponsors
collaborator

Sheffield Children's NHS Foundation Trust

OTHER

lead

Sheffield Hallam University

OTHER

NCT03144869 - Physical Activity Monitoring Paediatric Type 1 Diabetes | Biotech Hunter | Biotech Hunter